PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-01-09

Date Title Company
09-Jan-2025 MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test AccessWire
09-Jan-2025 Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness AccessWire
09-Jan-2025 Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment ABIVAX
09-Jan-2025 ClinicMind Ranked #1 for Chiropractic EHR and Practice Management in Black Book Research 2025 User Survey AccessWire
09-Jan-2025 CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis AccessWire
09-Jan-2025 Formycon included in TecDAX Index of Deutsche Börse Formycon AG
09-Jan-2025 Orlando Medical Waste Disposal Company Addresses Increase in Needlestick Injuries With Key Guide AccessWire
09-Jan-2025 BSI Software announces new Board of Directors BSI
09-Jan-2025 Lung cancer test predicts survival in early stages better than current methods Francis Crick Institute
09-Jan-2025 ICR welcomes NICE recommendation of olaparib for advanced breast cancer ICR
09-Jan-2025 NICE RECOMMENDS LYNPARZA (OLAPARIB) TO TREAT GERMLINE BRCA-MUTATED HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER CHEMOTHERAPY IN ENGLAND AND WALES AstraZeneca
09-Jan-2025 Alchemab Therapeutics enters into collaboration with Lilly to discover, research and develop novel therapies for ALS Alchemab Therapeutics
09-Jan-2025 Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology Astraveus
09-Jan-2025 Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines Coave Therapeutics
09-Jan-2025 As levels of LDL (‘bad’) cholesterol spike by 20% post-Christmas, how can we avoid becoming prediabetic? London Medical Laboratory
09-Jan-2025 New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma Sanofi
09-Jan-2025 Breakthrough Gene Editing Technique Offers Hope for Stargardt Disease Patients Institute of Molecular and Clinical Ophthalmology Basel (IOB)
09-Jan-2025 Merck launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeiting Merck
09-Jan-2025 Quest International Achieves ANSI/ESD Certification for German Facility, Strengthening International Depot Repair Services and Capabilities AccessWire
09-Jan-2025 Novadip appoints Drew Trivisonno to the board of directors to drive financial and business development Andrew Lloyd Associates